✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

SCHOTT Pharma AG & Co KgaA

Common Name
SCHOTT Pharma AG & Co
Country
Germany
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
4,839
Ticker
1SXP
Exchange
Deutsche Börse Frankfurt
Description
SCHOTT Pharma AG & Co. KGaA is a leading provider of drug containment and delivery solutions, specializing in primary packaging for injectable pharmaceuticals. Headquartered in Mainz, Germany, and par...

SCHOTT Pharma AG & Co's Waste Data Preview

In 2023, SCHOTT Pharma AG & Co conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023
Total Waste Generated
12,453a
Total Waste Recovered
9,906a
Total Hazardous Waste Generated
422a
Non-Hazardous Waste Disposed
2,307a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind SCHOTT Pharma AG & Co’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. SCHOTT Pharma AG & Co's Sustainability Report 2023

Insights into SCHOTT Pharma AG & Co's Waste Treatment Practices

In 2023, SCHOTT Pharma AG & Co generated a total of 12,453metric tonnes of waste.a

Of this amount, 79.55% of SCHOTT Pharma AG & Co's total waste generated was recovered through methods such as recycling, reuse, or composting, while 20.45% was disposed of through landfilling, incineration, or combustion.a

SCHOTT Pharma AG & Co's Waste Recovery Rate

80%

How much of SCHOTT Pharma AG & Co's waste is recycled or recovered?

In 2023, SCHOTT Pharma AG & Co reported a total waste generation of 12,453 metric tonnes, of which 79.55% was recovered through recycling, reuse, or composting.This high recovery rate suggests that SCHOTT Pharma AG & Co has implemented strong circular economy practices and actively prioritizes sustainable waste management.a

Insights into SCHOTT Pharma AG & Co’s Generation of Hazardous and Non-Hazardous Waste

In 2023, SCHOTT Pharma AG & Co generated a total of 12,453 metric tonnes of waste.a

Of this amount, 3.39% of SCHOTT Pharma AG & Co's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.96.61% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a

How does SCHOTT Pharma AG & Co treat its hazardous waste?

In 2023, SCHOTT Pharma AG & Co reported that 422 metric tonnes of its total waste output were classified as hazardous. This represents 3.39% of its overall waste generation.a

The company treated this hazardous waste using a combination of methods.Approximately 43.13% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.a

Breakdown of SCHOTT Pharma AG & Co's Hazardous and Non-Hazardous Waste by Treatment Method

Non-Hazardous WasteDisposed(18.5%)Non-Hazardous WasteRecovered(78.1%)
Want Full Access to SCHOTT Pharma AG & Co's Waste Management Dataset?
Start 30-Day Free Trial